Il trial AQUATIC: la fine dell’era dell’aspirina nei pazienti anticoagulati dopo angioplastica coronarica

Giornale italiano di cardiologia 2026

View at publisher

Authors: Felice Gragnano, Paolo Calabrò

DOI: 10.1714/4618.46263

Cited by: 0

Fields of Study & Subjects

Antiplatelet Therapy and Cardiovascular Diseases Atrial Fibrillation Management and Outcomes Acute Myocardial Infarction Research